Elastic 50 resin served as the material of choice. We confirmed the viability of successfully transmitting non-invasive ventilation, observing that the mask enhanced respiratory parameters and minimized the necessity for supplemental oxygen. The fraction of inspired oxygen (FiO2) was lowered from 45%, the customary setting for traditional masks, to almost 21% when a nasal mask was applied to the premature infant, who was either placed in an incubator or in a kangaroo-care position. Given these findings, a clinical trial is underway to assess the safety and effectiveness of 3D-printed masks for extremely low birth weight infants. 3D-printed masks, offering a customized alternative, could potentially provide a better fit for non-invasive ventilation in extremely low birth weight infants than the standard masks.
The development of functional biomimetic tissues using 3D bioprinting technologies is a promising direction in tissue engineering and regenerative medicine. In the context of 3D bioprinting, bio-inks are indispensable for the creation of the cellular microenvironment, subsequently impacting the effectiveness of biomimetic designs and regenerative processes. Mechanical properties within a microenvironment are distinguished by the attributes of matrix stiffness, viscoelasticity, topography, and dynamic mechanical stimulation. The possibility of engineering cell mechanical microenvironments in vivo has been realized with the emergence of engineered bio-inks, stemming from recent advancements in functional biomaterials. We present a summary of the vital mechanical signals in cellular microenvironments, analyze engineered bio-inks with a focus on the principles of construction for cell mechanical microenvironments, and delve into the challenges and potential solutions in this area.
Novel treatment options, including three-dimensional (3D) bioprinting, are being developed to preserve meniscal function. Yet, meniscal 3D bioprinting, including the selection of appropriate bioinks, has not been thoroughly examined. A bioink composed of alginate, gelatin, and carboxymethylated cellulose nanocrystals (CCNC) was developed and evaluated within the scope of this research. Bioinks, composed of varying concentrations of the previously cited components, were subjected to rheological analysis (amplitude sweep, temperature sweep, and rotational tests). The printing accuracy of a bioink composed of 40% gelatin, 0.75% alginate, 14% CCNC, and 46% D-mannitol was tested, and the outcome proceeded to 3D bioprinting with normal human knee articular chondrocytes (NHAC-kn). Encapsulated cell viability was greater than 98%, and the bioink induced a stimulation of collagen II expression. Biocompatible and printable, the formulated bioink maintains the native phenotype of chondrocytes, and is stable under cell culture conditions. Beyond the application of meniscal tissue bioprinting, this bioink is anticipated to function as a foundational element in creating bioinks for diverse tissue types.
Modern 3D printing, a computer-aided design-driven method, allows for the creation of 3-dimensional structures via sequential layer deposition. Increasing interest in bioprinting, a 3D printing application, stems from its ability to produce scaffolds for living cells with the extreme precision needed. Simultaneously with the expeditious advancement of three-dimensional bioprinting technology, the groundbreaking development of bio-inks, widely considered the most complex facet of this methodology, has shown exceptional potential for tissue engineering and regenerative medicine applications. From a natural standpoint, cellulose is the most abundant polymer. Bio-inks, formulated using various cellulose types, including nanocellulose and diverse cellulose derivatives such as cellulose ethers and esters, are now widely used in bioprinting applications, capitalizing on their biocompatibility, biodegradability, affordability, and printability. Despite the investigation of diverse cellulose-based bio-inks, the full scope of applications for nanocellulose and cellulose derivative-based bio-inks is still largely undefined. The focus of this review is on the physical and chemical attributes of nanocellulose and cellulose derivatives, coupled with the latest innovations in bio-ink design techniques for three-dimensional bioprinting of bone and cartilage structures. Subsequently, the current advantages and disadvantages of these bio-inks and their expected role within the framework of 3D printing for tissue engineering are comprehensively reviewed. For the sake of this sector, we hope to provide helpful information on the logical design of innovative cellulose-based materials in the future.
Skull defects are addressed via cranioplasty, a procedure that involves detaching the scalp, then reshaping the skull using autogenous bone, titanium mesh, or a biocompatible substitute. JNJ-64619178 in vivo Additive manufacturing (AM), better known as 3D printing, is now used by medical professionals to create personalized replicas of tissues, organs, and bones. This method is an acceptable and anatomically accurate option for skeletal reconstruction. This report details a case in which titanium mesh cranioplasty was performed 15 years past. The titanium mesh's poor visual appeal was a contributing factor to the weakening of the left eyebrow arch, leading to a sinus tract. The surgical cranioplasty procedure incorporated an additively manufactured polyether ether ketone (PEEK) skull implant. Without encountering any difficulties, PEEK skull implants have been successfully placed. This is, to our awareness, the first reported instance of a cranial repair application employing a directly utilized PEEK implant created using the fused filament fabrication (FFF) method. The FFF-printed PEEK customized skull implant boasts adjustable material thickness and a complex structure, allowing for tunable mechanical properties and reduced processing costs when compared with traditional methods. In order to address clinical needs, this manufacturing process stands as a suitable alternative to the use of PEEK materials in cranioplasties.
Hydrogels, especially in three-dimensional (3D) bioprinting techniques, are proving essential in biofabrication, garnering increasing attention. This focus is driven by the capability of producing complex 3D tissue and organ structures mimicking the intricate designs of native tissues, exhibiting cytocompatibility and supporting cellular growth following the printing procedure. In contrast to others, some printed gels display poor stability and limited shape maintenance when factors like polymer nature, viscosity, shear-thinning capabilities, and crosslinking are impacted. Consequently, researchers have employed a strategy of incorporating different types of nanomaterials as bioactive fillers into polymeric hydrogels to overcome these limitations. Printed gels have been engineered to incorporate carbon-family nanomaterials (CFNs), hydroxyapatites, nanosilicates, and strontium carbonates, thus enabling diverse biomedical applications. This review, drawing conclusions from a compilation of research on CFNs-containing printable gels across a multitude of tissue engineering applications, analyzes different bioprinter types, the essential characteristics of bioinks and biomaterial inks, and the progress made and the challenges faced by this technology.
Additive manufacturing provides a means to create customized bone replacements. Filament extrusion is the most widespread three-dimensional (3D) printing method in use at the current time. Hydrogels, integral to bioprinting's extruded filaments, encapsulate growth factors and cells within their structure. This study's approach to 3D printing, based on lithographic techniques, aimed to duplicate filament-based microarchitectures by manipulating filament dimensions and inter-filament separation. JNJ-64619178 in vivo Scaffold filaments, in the initial set, exhibited a uniform orientation aligned with the bone's ingress trajectory. JNJ-64619178 in vivo A second set of scaffolds, constructed with the same underlying microarchitecture but angled ninety degrees differently, had only half their filaments oriented in the direction of bone ingrowth. A rabbit calvarial defect model was utilized to assess the osteoconduction and bone regeneration capabilities of all tricalcium phosphate-based constructs. The results of the study definitively showed that if filaments followed the trajectory of bone ingrowth, the size and spacing of the filaments (0.40-1.25 mm) had no notable effect on the process of defect bridging. Nevertheless, a 50% alignment of filaments resulted in a substantial decrease in osteoconductivity as filament size and spacing grew. Therefore, regarding filament-based 3D or bio-printed bone replacements, a filament spacing between 0.40 and 0.50 millimeters is required, independent of the orientation of bone ingrowth, reaching 0.83 mm if the orientation is consistent with bone ingrowth.
Innovative bioprinting techniques offer a new direction in combating the global organ shortage. Although recent technological strides have been made, the limitations of printing resolution still hinder the progress of bioprinting. Ordinarily, the machine's axial movements fail to provide a dependable method for predicting material placement, and the printing path frequently deviates from the pre-established design trajectory by varying amounts. This study presented a computer vision-based system to correct trajectory deviations and consequently improve printing accuracy. The image algorithm used the printed trajectory and the reference trajectory to calculate an error vector, reflecting the deviation between them. Moreover, the trajectory of the axes was adjusted using the normal vector method during the second print run to counteract the error stemming from the deviation. Ninety-one percent was the upper limit of correction efficiency. Importantly, we observed, for the very first time, a normal distribution of the correction results, contrasting with the previously observed random distribution.
Chronic blood loss and accelerated wound healing demand the indispensable creation of multifunctional hemostats. Within the last five years, considerable strides have been made in the development of hemostatic materials, improving both wound repair and the speed of tissue regeneration. The latest technologies, electrospinning, 3D printing, and lithography, have been utilized in developing 3D hemostatic platforms, used individually or in concert, to bring about rapid wound healing, as analyzed in this review.